<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref21">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bonfanti</surname>
    <given-names>J.-F.</given-names>
   </name>
   <name>
    <surname>Meyer</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Doublet</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Fortin</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Muller</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Queguiner</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2008</year>). 
  <article-title>Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121)</article-title>. 
  <source>J. Med. Chem.</source>
  <volume>51</volume>, 
  <fpage>875</fpage>â€“
  <lpage>896</lpage>. 
  <pub-id pub-id-type="doi">10.1021/jm701284j</pub-id>, PMID: 
  <?supplied-pmid 18254606?>
  <pub-id pub-id-type="pmid">18254606</pub-id>
 </mixed-citation>
</ref>
